Dual-port Trans-subclavian Thyroid Endoscopic Surgery

This is a prospective, single-center, open-label, non-randomized controlled real-world study aimed at exploring a novel approach to cavity construction for thyroid endoscopic surgery. The study seeks to evaluate its effectiveness and safety while accumulating further evidence-based medical data. Three hundred patients with thyroid tumors were divided into an experimental group (150 cases receiving a new endoscopic thyroid surgery technique, namely, dual-port trans-subclavian thyroid endoscopic surgery) and a control group (150 cases undergoing traditional open thyroid surgery) according to th

Trial Details

NCT ID
NCT06398795
Phase
NA
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Dual-port Trans-subclavian Thyroid Endoscopic Surgery (DTS).
  • Conventional open thyroidectomy (COT)
Locations (sample)
  • Wenzhou, Zhejiang, China|27.99942,120.66682

Key Eligibility Criteria

  • Thyroid cancer or benign thyroid tumors
  • Patients with a demand for incisional cosmetic improvement

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →